Figures & data
Table 1 Clinical characteristics of the patients receiving iodixanol or iohexol group
Table 2 Change in serum creatinine on day 0–7 following intravenous pyelography
Table 3 Percentage change serum creatinine of the different groups patients receiving iodixanol or iohexol group
Table 4 Cytokine profiles in patients receiving iodixanol or iohexol bolus injections
Table 5 Early (<1 hour) and late (>1 hour to 7 days) allergic reactions in patients receiving iodixanol or iohexol bolus injections
Figure 1 The patient received 80 ml intravenous iodixanol injection and developed late adverse reaction over upper extremities and trunk eight hours later, and then spread to low abdominal area and inguinal region. The skin lesion improved nine days after therapy.
